These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15633997)

  • 1. Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.
    Bolognesi ML; Andrisano V; Bartolini M; Banzi R; Melchiorre C
    J Med Chem; 2005 Jan; 48(1):24-7. PubMed ID: 15633997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.
    Tumiatti V; Milelli A; Minarini A; Rosini M; Bolognesi ML; Micco M; Andrisano V; Bartolini M; Mancini F; Recanatini M; Cavalli A; Melchiorre C
    J Med Chem; 2008 Nov; 51(22):7308-12. PubMed ID: 18954037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
    Muñoz-Ruiz P; Rubio L; García-Palomero E; Dorronsoro I; del Monte-Millán M; Valenzuela R; Usán P; de Austria C; Bartolini M; Andrisano V; Bidon-Chanal A; Orozco M; Luque FJ; Medina M; Martínez A
    J Med Chem; 2005 Nov; 48(23):7223-33. PubMed ID: 16279781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties.
    Tumiatti V; Andrisano V; Banzi R; Bartolini M; Minarini A; Rosini M; Melchiorre C
    J Med Chem; 2004 Dec; 47(26):6490-8. PubMed ID: 15588084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.
    Rosini M; Simoni E; Bartolini M; Cavalli A; Ceccarini L; Pascu N; McClymont DW; Tarozzi A; Bolognesi ML; Minarini A; Tumiatti V; Andrisano V; Mellor IR; Melchiorre C
    J Med Chem; 2008 Aug; 51(15):4381-4. PubMed ID: 18605718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of acetylcholinesterase peripheral anionic site ligands through computational refinement of a directed library.
    Dickerson TJ; Beuscher AE; Rogers CJ; Hixon MS; Yamamoto N; Xu Y; Olson AJ; Janda KD
    Biochemistry; 2005 Nov; 44(45):14845-53. PubMed ID: 16274232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Bartolini M; Bottegoni G; Bisi A; Cavalli A; Andrisano V; Rampa A
    Eur J Med Chem; 2011 May; 46(5):1682-93. PubMed ID: 21397996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
    Camps P; Formosa X; Galdeano C; Muñoz-Torrero D; Ramírez L; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Huertas O; Dafni T; Luque FJ
    J Med Chem; 2009 Sep; 52(17):5365-79. PubMed ID: 19663388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease.
    Melchiorre C; Andrisano V; Bolognesi ML; Budriesi R; Cavalli A; Cavrini V; Rosini M; Tumiatti V; Recanatini M
    J Med Chem; 1998 Oct; 41(22):4186-9. PubMed ID: 9784091
    [No Abstract]   [Full Text] [Related]  

  • 12. 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy.
    Piazzi L; Rampa A; Bisi A; Gobbi S; Belluti F; Cavalli A; Bartolini M; Andrisano V; Valenti P; Recanatini M
    J Med Chem; 2003 Jun; 46(12):2279-82. PubMed ID: 12773032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitooligosaccharides suppress the level of protein expression and acetylcholinesterase activity induced by Abeta25-35 in PC12 cells.
    Lee SH; Park JS; Kim SK; Ahn CB; Je JY
    Bioorg Med Chem Lett; 2009 Feb; 19(3):860-2. PubMed ID: 19097785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.
    Xie Q; Wang H; Xia Z; Lu M; Zhang W; Wang X; Fu W; Tang Y; Sheng W; Li W; Zhou W; Zhu X; Qiu Z; Chen H
    J Med Chem; 2008 Apr; 51(7):2027-36. PubMed ID: 18333606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues.
    Zhou X; Wang XB; Wang T; Kong LY
    Bioorg Med Chem; 2008 Sep; 16(17):8011-21. PubMed ID: 18701305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors.
    Shen Q; Peng Q; Shao J; Liu X; Huang Z; Pu X; Ma L; Li YM; Chan AS; Gu L
    Eur J Med Chem; 2005 Dec; 40(12):1307-15. PubMed ID: 16182411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases.
    Alptüzün V; Prinz M; Hörr V; Scheiber J; Radacki K; Fallarero A; Vuorela P; Engels B; Braunschweig H; Erciyas E; Holzgrabe U
    Bioorg Med Chem; 2010 Mar; 18(5):2049-59. PubMed ID: 20149667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.
    Tumiatti V; Rosini M; Bartolini M; Cavalli A; Marucci G; Andrisano V; Angeli P; Banzi R; Minarini A; Recanatini M; Melchiorre C
    J Med Chem; 2003 Mar; 46(6):954-66. PubMed ID: 12620072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.